skip to contentskip to secondary navigation
Getting to the centre 03 9496 5000
Make a difference
Donate
  • Patients & family
    • Becoming our patient
      • How to become an ONJ patient
      • Planning for your care
    • Diagnosis & Treatment
      • Cancer types
      • A new diagnosis
      • Cancer treatment
      • Your Wellness matters
      • Commonly asked questions
    • Clinical Haematology
      • Allogeneic stem cell transplant
      • Autologous stem cell transplant
    • Visitors
  • For health professionals
    • What we do
      • Cancer types & treatment
    • Referral
      • Referral for treatment
      • Referral to palliative care
    • Careers at Austin Health
  • Research
    • Cancer Clinical Trials
    • Psycho-Oncology research
    • Olivia Newton-John Cancer Research Institute
  • About
    • Maps & directions
    • A public hospital with a difference
    • Dame Olivia Newton-John
    • Contact us
  • Ways to help
    • Ways to help today
      • Leave a gift in your Will
      • Support research
      • USA Donations
      • Become a hero today
    • Get Involved
      • Attend an event
      • Corporate partnerships
      • Volunteering
      • Dry July
    • How your gift helps
      • Why I give
      • People you've helped
    • We'll be here for you...but we need your help

Shopping Cart

There are no products in your cart.
150813-jamesbraund-0167

Dr Doug Fairlie

HEAD, CELL DEATH and SURVIVAL LABORATORY

More about Dr Doug Fairlie

I am especially excited about making discoveries in fundamental molecular and cellular processes, and subsequently translating these findings into the development of new treatment strategies that will ultimately benefit cancer patients.

I obtained my PhD in Biochemistry from Monash University in 1994. After a postdoctoral stint in the US at the State University of New York, Buffalo, I returned to Australia in 1996 to work at the Centre for Immunology, St Vincent’s Hospital, Sydney, where I was the lead protein chemist on projects involving TGF-b-related cytokines and a novel intracellular ion channel.

In 2001, I joined the Cancer and Haematology Division at the Walter and Eliza Hall Institute to continue work on cytokines, including IL-6 family members. In 2003, I moved to the Structural Biology Division at WEHI, where I commenced working on cell death and survival mechanisms, and was promoted to a laboratory head in 2010.

Upon joining the ONJCRI in 2015, I have focused on understanding how cell death is regulated in melanoma and am currently working with colleagues at WEHI to develop new drugs which target the apoptosis pathways in these and other tumours. My work is funded through grants from NHMRC, Cancer Council of Victoria and Worldwide Cancer Research, UK.

Education

PhD, Biochemistry, Monash University

 

Ph: +61 3 9496 9369

Email: doug.fairlie@onjcri.org.au

  • Home
  • Ways to help
  • Patients & family
  • For health professionals
  • Research
  • News
  • About
  • ONJ-events
  • Research
AustinHealth_Logo
 
Connect with us

Keep up to date with what’s happening at the ONJ Centre.

   

Call us

03 9496 5000

Calling from overseas

+613 9496 5000

Address

145 Studley Road (On the corner of Studley Rd and Bell St) Heidelberg, Victoria, Australia.